Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.160
+0.020 (0.64%)
Nov 20, 2024, 4:00 PM EST - Market closed

Atea Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
75
Market Cap
266.90M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021351.37M302.73M622.49%
Dec 31, 202048.63M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accolade 441.03M
AngioDynamics 292.73M
OraSure Technologies 224.26M
Poseida Therapeutics 150.86M
NeuroPace 76.45M
Mersana Therapeutics 34.84M
Eton Pharmaceuticals 34.68M
Ocugen 4.70M
Revenue Rankings